Sugar Editorial Picks
Jul 05, 2007 -
I don't think it's very lady-like to talk about sweat, but I can admit when my mobile weatherman hits 80 I start to get a little, well, sweaty. While most of us respond to warm temperatures by shedding layers and drinking more iced tea, one company hopes people will take it one step further by cooling off with air conditioned clothes. Kuchofuku, a company that specializes in air-con lifestyle products, has introduced air conditioned pants and shirts for both men and women.
- 21 Comments
Other Search Results
Sep 10, 2009 -
Blistery hot Summer weather is cooling down, so those of you who were running in air-conditioned gyms can now move your workouts outside. Not only can you can advantage of the fresh air and nonexistent monthly fee, but if you opt for trail running instead of hitting the sidewalk or bike path, you'll end up burning 10 percent more calories. Keep these tips in mind when switching from the treadmill to the trails.
- 5 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Causes
- Prognosis
- Risk Factors
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Omalizumab is approved for patients who have moderate-to-severe asthma related to allergies and whose symptoms are not controlled by inhaled corticosteroids. It is given by injection in a doctor’s office every 2 - 4 weeks.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Prognosis
- Risk Factors
- Symptoms
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Health care providers need to carefully observe patients for 2 hours after they receive an omalizumab injection. However, because an allergic reaction can occur up to 24 hours after the injection, patients need to know the signs and symptoms of anaphylaxis and how to self-administer emergency treatment.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Complications
- Diagnosis
- Prevention
- Treatment for Acute Sinusit...
- Treatment for Chronic Sinus...
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Restriction
In February 2007, the FDA announced that the antibiotic telithromycin (Ketek) should no longer be used for treatment of acute bacterial sinusitis. In June 2006, the FDA reported that several people had died of liver damage after taking this drug. Telithromycin is now only approved for treatment of community-acquired pneumonia.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Complications
- Barrett's Esophagus
- Diagnosis
- Treatment
- Prevention
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
New Research
- Obesity and GERD. Increased weight in women is linked to more frequent GERD symptoms, according to the Nurses' Health Study, which included 10,545 female participants. Overweight and obese women were two to three times more likely to have frequent symptoms than women of normal weight.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Other Treatments
- Decongestants
- Antihistamines
- Corticosteroids
- Immunotherapy
- Prevention
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
Ciclesonide (Omanaris), a corticosteroid nasal spray, has been approved for treatment of seasonal and perennial allergic rhinitis (hay fever) in adults and children age 12 years and older.
FDA Drug Warnings
- The antihistamine promethazine (Phenergan) should not be given to children younger than age 2 because it may cause serious breathing problems.
- Omalizumab (Xolair) may cause a life-threatening allergic reaction (anaphylaxis). This drug is used to treat allergy-related asthma, but is also being investigated as an allergy treatment.
Cough and Cold Medicines for Children
In 2007, the FDA began reviewing the safety and effectiveness of cough and cold medicines for children.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Prognosis
- Symptoms
- Diagnosis
- Treatment
- Managing Scoliosis
- Braces
- Surgery
- Treatment for Adult Scolios...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Diagnosing Scoliosis
Scoliosis is diagnosed typically in children 10 - 15 years of age. However, only about 1% of cases actually require treatment. There is a large female preponderance for larger curves that do require treatment.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Recommended Exercise Method...
- Exercise's Effects on the H...
- Exercise's Effects on Diabe...
- Exercise's Effects on Bones...
- Exercise's Effects on the L...
- Exercise's Effects on Weigh...
- Exercise's Effects on Other...
- Complications
- Motivation
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Chronic Conditions and Exercise:
- A new study found that aerobic and resistance training significantly reduced fatigue in men undergoing radiation treatments for prostate cancer. Fatigue is a common side effect of such treatments.
- Doctors at the Mayo Clinic found that exercise improves the physical and emotional well-being of patients with Alzheimer's disease. The patients exercised for as little as 60 minutes each week.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Transmission
- Risk Factors
- Complications
- Diagnosis
- Similar Conditions
- Home Remedies and Preventio...
- Treatment for Genital Herpe...
- Treatment for Oral Herpes...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Herpes Diagnosis
In 2006, the U.S. Centers for Disease Control (CDC) released updated guidelines for diagnosis and management of sexually transmitted diseases.
- For diagnosis of genital herpes, the CDC recommends the use of both skin and blood tests.
- Blood (or type-specific serologic) tests must be able to detect antibodies to glycoprotein G (gG).
- 0 Comments